- Adageis focuses on empowering healthcare providers with tools and insights to excel in value-based care models, using a provider-centric approach.
- The company’s patented AI solutions enable providers to identify high-risk patients and address care gaps effectively.
- Its ProActive Care Platform integrates seamlessly with existing EHR systems to enhance patient outcomes and operational efficiency.
- A unique offering in the healthcare technology space, the platform offers flexible integration, proactive efficiency, and advanced predictive analysis capabilities.
Adageis, a healthcare technology company, is taking a bold stance in reshaping the healthcare landscape by prioritizing providers in the transition to value-based care. Unlike traditional models that often burden clinicians with administrative complexities, the Adageis provider-centric focus offers solutions designed to streamline workflows and align incentives with quality care outcomes.
Central to this approach is the company’s ProActive Care Platform, a patented AI-powered system that provides actionable insights to healthcare providers. The platform equips Accountable Care Organizations (“ACOs”), Clinically Integrated Networks (“CINs”), and…
NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
